CROMER GROUP PRACTICE
MILL ROAD, CROMERCHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 476 | 509 | 93.5% | |
CHD 9 | 2006 | 578 | 596 | 97.0% | |
CHD 9 | 2007 | 583 | 629 | 92.7% | |
CHD 9 | 2008 | 586 | 637 | 92.0% | |
CHD 9 | 2009 | 578 | 632 | 91.5% | |
CHD 9 | 2010 | 588 | 643 | 91.4% | |
CHD 9 | 2011 | 604 | 652 | 92.6% | |
CHD 9 | 2012 | 608 | 672 | 90.5% | |
CHD 9 | 2013 | 605 | 665 | 91.0% | |
CHD005 | 2014 | 633 | 655 | 96.6% | |
CHD005 | 2015 | 634 | 653 | 97.1% | |
CHD005 | 2016 | 623 | 648 | 96.1% | |
CHD005 | 2017 | 591 | 601 | 98.3% | |
CHD005 | 2018 | 566 | 573 | 98.8% | |
CHD005 | 2019 | 583 | 608 | 95.9% | |
CHD005 | 2020 | 591 | 591 | 100.0% | |
CHD005 | 2021 | 554 | 650 | 85.2% | |
CHD005 | 2022 | 543 | 559 | 97.1% | |
CHD005 | 2023 | 519 | 607 | 85.5% |